ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,140.40
0.69%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.745
-0.65%
Bitcoin
67,458.45
-1.03%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Disc Medicine Inc (IRON)

  7. Disc Medicine Inc (IRON) News

IRON

Disc Medicine (IRON)

Disc Medicine Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:IRON
DateTimeSourceHeadlineSymbolCompany
06/14/20244:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
06/14/20244:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
06/14/20244:01PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IRONDisc Medicine Inc
06/14/20248:03AMGlobeNewswire Inc.Disc Medicine Announces Underwritten Offering of Common StockNASDAQ:IRONDisc Medicine Inc
06/14/20247:36AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
06/14/20247:30AMGlobeNewswire Inc.Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
05/30/20249:00AMGlobeNewswire Inc.Disc Medicine to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:IRONDisc Medicine Inc
05/14/202410:30AMGlobeNewswire Inc.Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 CongressNASDAQ:IRONDisc Medicine Inc
05/13/20248:00AMGlobeNewswire Inc.Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor ConferenceNASDAQ:IRONDisc Medicine Inc
05/09/20248:15AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IRONDisc Medicine Inc
05/09/20248:07AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
05/09/20248:00AMGlobeNewswire Inc.Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
04/01/20248:00AMGlobeNewswire Inc.Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)NASDAQ:IRONDisc Medicine Inc
03/21/20248:00AMGlobeNewswire Inc.Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:IRONDisc Medicine Inc
03/06/20244:30PMGlobeNewswire Inc.Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024NASDAQ:IRONDisc Medicine Inc
03/01/20247:49PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
03/01/20247:39PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
03/01/20247:38PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
03/01/20247:36PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IRONDisc Medicine Inc
02/26/20248:43AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
02/26/20248:30AMGlobeNewswire Inc.Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial OfficerNASDAQ:IRONDisc Medicine Inc
02/20/20248:30AMGlobeNewswire Inc.Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney DiseaseNASDAQ:IRONDisc Medicine Inc
02/15/20244:22PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
02/13/20246:51PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:IRONDisc Medicine Inc
02/09/20249:00AMGlobeNewswire Inc.Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia VeraNASDAQ:IRONDisc Medicine Inc
02/07/20248:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:IRONDisc Medicine Inc
02/07/20248:00AMGlobeNewswire Inc.Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating OfficerNASDAQ:IRONDisc Medicine Inc
02/06/20244:55PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
01/23/20245:48PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
01/04/20244:24PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:IRONDisc Medicine Inc
 Showing the most relevant articles for your search:NASDAQ:IRON

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
NSAV
Net Savings Link (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved